<DOC>
	<DOCNO>NCT01136564</DOCNO>
	<brief_summary>Recently document vitamin D important function human body unrelated primary effect calcium homeostasis bone mineralization . In clinical study , paricalcitol - low-calcemic vitamin D analogue - show decrease proteinuria , marker disease progression cardiovascular risk patient chronic kidney disease ( CKD ) . The purpose study investigate effect paricalcitol renal cardiovascular variable patient moderate severe CKD .</brief_summary>
	<brief_title>Reno- Vascular Protective Effect Vitamin-D-analogue Moderate Severe Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Kidney disease correspond eGFR : 1559 ml/min Albuminuria &gt; 30 mg/l Total parathyroidectomy Diabetes Mellitus Cancer Illicit drug alcohol abuse Pregnancy og nurse Ongoing NSAID corticosteroid treatment bhemoglobin &lt; 6 mmol/l palbumin &lt; 25 mmol/l Clinically significant hypercalcemia Office blood pressure &gt; 170/105 mmHg despite antihypertensive treatment still &gt; 170/105 mmHg use home blood pressure measurements 24hour ambulatory blood pressure measurement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>paricalcitol</keyword>
	<keyword>vitamin</keyword>
	<keyword>kidney disease</keyword>
	<keyword>renin</keyword>
	<keyword>proteinuria</keyword>
</DOC>